Active Juvenile Psoriatic Arthritis

Drug	Drug Name	Drug Description
DB00005	Etanercept	A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.

Drug	Drug Name	Target	Type
DB00005	Etanercept	Tumor necrosis factor	target
DB00005	Etanercept	Lymphotoxin-alpha	target
DB00005	Etanercept	Low affinity immunoglobulin gamma Fc region receptor III-B	target
DB00005	Etanercept	Low affinity immunoglobulin gamma Fc region receptor III-A	target
DB00005	Etanercept	High affinity immunoglobulin gamma Fc receptor I	target
DB00005	Etanercept	Low affinity immunoglobulin gamma Fc region receptor II-a	target
DB00005	Etanercept	Low affinity immunoglobulin gamma Fc region receptor II-b	target
DB00005	Etanercept	Low affinity immunoglobulin gamma Fc region receptor II-c	target
DB00005	Etanercept	Complement component 1q (C1q)	target

Drug	Drug Name	Phase	Status	Count
DB05676	Apremilast	3	Recruiting	1